» Articles » PMID: 8356074

Three-dimensional Structure of a Heteroclitic Antigen-antibody Cross-reaction Complex

Overview
Specialty Science
Date 1993 Aug 15
PMID 8356074
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Although antibodies are highly specific, cross-reactions are frequently observed. To understand the molecular basis of this phenomenon, we studied the anti-hen egg lysozyme (HEL) monoclonal antibody (mAb) D11.15, which cross-reacts with several avian lysozymes, in some cases with a higher affinity (heteroclitic binding) than for HEL. We have determined the crystal structure of the Fv fragment of D11.15 complexed with pheasant egg lysozyme (PHL). In addition, we have determined the structure of PHL, Guinea fowl egg lysozyme, and Japanese quail egg lysozyme. Differences in the affinity of D11.15 for the lysozymes appear to result from sequence substitutions in these antigens at the interface with the antibody. More generally, cross-reactivity is seen to require a stereochemically permissive environment for the variant antigen residues at the antibody-antigen interface.

Citing Articles

BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis.

Paran F, Oyama R, Khasawneh A, Ai T, Ismanto H, Sherif A Front Immunol. 2024; 15:1405013.

PMID: 39530088 PMC: 11550956. DOI: 10.3389/fimmu.2024.1405013.


Antibody Cross-Reactivity in Auto-Immune Diseases.

Trier N, Houen G Int J Mol Sci. 2023; 24(17).

PMID: 37686415 PMC: 10487534. DOI: 10.3390/ijms241713609.


Characterization of an HNA aptamer suggests a non-canonical G-quadruplex motif.

Schofield P, Taylor A, Rihon J, Pena Martinez C, Zinn S, Mattelaer C Nucleic Acids Res. 2023; 51(15):7736-7748.

PMID: 37439359 PMC: 10450178. DOI: 10.1093/nar/gkad592.


Restricted epitope specificity determined by variable region germline segment pairing in rodent antibody repertoires.

Hsiao Y, Chen Y, Goldstein L, Wu J, Lin Z, Schneider K MAbs. 2020; 12(1):1722541.

PMID: 32041466 PMC: 7039645. DOI: 10.1080/19420862.2020.1722541.


Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope.

Weidenbacher P, Kim P Proc Natl Acad Sci U S A. 2019; 116(20):9947-9952.

PMID: 31028143 PMC: 6525525. DOI: 10.1073/pnas.1822062116.


References
1.
Bhat T, Bentley G, Fischmann T, Boulot G, POLJAK R . Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding. Nature. 1990; 347(6292):483-5. DOI: 10.1038/347483a0. View

2.
Fischmann T, Bentley G, Bhat T, Boulot G, Mariuzza R, Phillips S . Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. J Biol Chem. 1991; 266(20):12915-20. View

3.
Harper M, Lema F, Boulot G, POLJAK R . Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies. Mol Immunol. 1987; 24(2):97-108. DOI: 10.1016/0161-5890(87)90081-2. View

4.
Karlsson R, Michaelsson A, Mattsson L . Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods. 1991; 145(1-2):229-40. DOI: 10.1016/0022-1759(91)90331-9. View

5.
Guillon V, Alzari P, POLJAK R . Preliminary crystallographic study of a complex between an heteroclitic anti-hen egg-white lysozyme antibody and the heterologous antigen pheasant egg-white lysozyme. J Mol Biol. 1987; 197(2):375-6. DOI: 10.1016/0022-2836(87)90132-x. View